Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials

Go back to Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials
(NASDAQ: WVE) Delayed: 13.12 -0.08 (0.61%)
Previous Close $13.20    52 Week High $38.50 
Open $13.22    52 Week Low $8.95 
Day High $13.40    P/E N/A 
Day Low $12.93    EPS $0.00 
Volume 2,472,830       

(NASDAQ: WVE) Delayed: 13.12 -0.08 (0.61%)
Previous Close $13.20    52 Week High $38.50 
Open $13.22    52 Week Low $8.95 
Day High $13.40    P/E N/A 
Day Low $12.93    EPS $0.00 
Volume 2,472,830